| 000 | 01634 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514222705.0 | ||
| 264 | 0 | _c20050504 | |
| 008 | 200505s 0 0 eng d | ||
| 022 | _a1352-4585 | ||
| 024 | 7 |
_a10.1191/1352458505ms1132oa _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBaumhackl, U | |
| 245 | 0 | 0 |
_aA randomized, double-blind, placebo-controlled study of oral hydrolytic enzymes in relapsing multiple sclerosis. _h[electronic resource] |
| 260 |
_bMultiple sclerosis (Houndmills, Basingstoke, England) _cApr 2005 |
||
| 300 |
_a166-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 |
_aBromelains _xadministration & dosage |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aRutin _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTrypsin _xadministration & dosage |
| 700 | 1 | _aKappos, L | |
| 700 | 1 | _aRadue, E W | |
| 700 | 1 | _aFreitag, P | |
| 700 | 1 | _aGuseo, A | |
| 700 | 1 | _aDaumer, M | |
| 700 | 1 | _aMertin, J | |
| 773 | 0 |
_tMultiple sclerosis (Houndmills, Basingstoke, England) _gvol. 11 _gno. 2 _gp. 166-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1191/1352458505ms1132oa _zAvailable from publisher's website |
| 999 |
_c15465136 _d15465136 |
||